vimarsana.com

SK bioscience began its domestic supply of Novavax’s updated COVID-19 vaccine, which targets the XBB.1.5 variant, Dec. 18, as part of the country’s effort to provide a wider range of vaccine choices in addition to mRNA-based vaccines, according to the vaccine maker, Sunday.

Related Keywords

Gyeonggi ,Kyonggi Do ,South Korea ,Seongnam ,Baek Byung Yeul ,Ahn Jae Yong , ,Ministry Of Food ,Drug Safety ,Gyeonggi Province ,Vaccine ,Vaccination ,Way ,Percent ,Safety ,Infection ,Experts ,Approval ,Rate ,Korea ,He Korea Times ,Orea Times ,Oreatimes ,Orean News In English ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.